BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 163995)

  • 1. Progesterone concentration in placenta, molar tissue, and ovarian theca lutein cyst.
    Dawood MY; Teoh ES; Das NP
    Obstet Gynecol; 1975 Feb; 45(2):171-4. PubMed ID: 163995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone in molar vesicle fluid and theca lutein cyst fluid.
    Dawood MY
    Obstet Gynecol; 1975 May; 45(5):531-6. PubMed ID: 1124167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of serum progesterone: after normal delivery and removal of hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1975 Jan; 45(1):9-12. PubMed ID: 1110825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the concentration of chorionic gonadotropin (HCG) and its free subunits in placental tissue during various periods of normal pregnancy].
    Rozmus M; Skalba P
    Zentralbl Gynakol; 1984; 106(12):834-44. PubMed ID: 6475396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 17 alpha-hydroxyprogesterone in patients with gestational trophoblastic neoplasms.
    Osathanondh R; Goldstein DP; Tulchinsky D; Finn AE
    Obstet Gynecol; 1977 Jan; 49(1):77-9. PubMed ID: 187990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone in the molar vesicle fluid and theca-lutein cyst fluid.
    Chew PC; Ratnam SS; Goh HH
    Br J Obstet Gynaecol; 1978 Mar; 85(3):218-20. PubMed ID: 629902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of theca lutein cysts.
    Montz FJ; Schlaerth JB; Morrow CP
    Obstet Gynecol; 1988 Aug; 72(2):247-51. PubMed ID: 2455880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissue.
    Osathanondh R; Elkind-Hirsch KE
    Placenta Suppl; 1981; 3():257-61. PubMed ID: 6763999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free estriol and estriol glucuronide fractions in hydatidiform mole measured by radioimmunoassay.
    Dawood MY; Brown JB; Newnam KL
    Obstet Gynecol; 1977 Mar; 49(3):303-7. PubMed ID: 840458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The source of circulating progesterone and 17 -hydroxyprogesterone in hydatidiform mole.
    Teoh ES; Das NP; Dawood MY; Ratnam SS
    Acta Endocrinol (Copenh); 1972 Dec; 71(4):773-80. PubMed ID: 4343782
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the production of chorionic gonadotropin by the cells of trophoblastic tumors (immunohistochemical research)].
    Pozharisskiĭ KM; Zueva EE; Nikitin AIu
    Vopr Onkol; 1988; 34(8):945-51. PubMed ID: 2844022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole.
    Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O
    Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein distribution in hydatidiform mole. An immunohistochemical study.
    Massi G; Coli A; De Carolis S
    Arch Pathol Lab Med; 1987 Aug; 111(8):723-5. PubMed ID: 3307688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S; Searle RF; Bulmer JN
    Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of steroid disruption using cultures of whole ovary and/or placenta in rat and in human placental tissue.
    Piasek M; Laskey JW; Kostial K; Blanusa M
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S36-44. PubMed ID: 12397409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transforming growth factor-beta and insulin-like growth factor in molar and placental tissues.
    Pang ZJ; Xing FQ
    Arch Gynecol Obstet; 2003 Nov; 269(1):1-4. PubMed ID: 14605814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive oxytocin in human placental tissue.
    Nakazawa K; Makino T; Nagai T; Suzuki H; Iizuka R
    Endocrinol Exp; 1984 Mar; 18(1):35-41. PubMed ID: 6609066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of complete and partial molar pregnancy.
    Goldstein DP; Berkowitz RS
    J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.